LACTB and LC3 could serve as potential biomarkers of gastric cancer to neoadjuvant chemotherapy with oxaliplatin plus S-1

The present study investigated and evaluated the correlation between the expression of LACTB and LC3 and the clinical outcomes of patients with advanced gastric cancer treated with oxaliplatin plus S-1 neoadjuvant chemotherapy (NACT). A total of 51 patients with advanced gastric cancer underwent NAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fang, Yan, Zhiqiang, Nie, Wei, Liu, Zeying, Cheng, Xingzhen, Wang, Wei, Shao, Chunyan, Fu, Gui, Yu, Yanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063359/
https://www.ncbi.nlm.nih.gov/pubmed/33907580
http://dx.doi.org/10.3892/ol.2021.12731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063359/
https://www.ncbi.nlm.nih.gov/pubmed/33907580
http://dx.doi.org/10.3892/ol.2021.12731

Ejemplares similares